{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T20:38:01Z","timestamp":1696970281874},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,3]]},"DOI":"10.1093\/eurheartj\/ehab906","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T22:46:12Z","timestamp":1644360372000},"page":"351-354","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of heart failure across the spectrum of left ventricular ejection fraction and an update on cardiac amyloidosis and ischaemic cardiomyopathy"],"prefix":"10.1093","volume":"43","author":[{"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"},{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"2022020922144217300_ehab906-B1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/eurheartj\/ehab887","article-title":"The year in cardiovascular medicine 2021: heart failure and cardiomyopathies","volume":"43","author":"Bauersachs","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/eurheartj\/ehab884","article-title":"The year in cardiovascular medicine 2021: interventional cardiology","volume":"43","author":"Escaned","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/eurheartj\/ehy611","article-title":"Defibrillator therapy for non-ischaemic cardiomyopathy: are sharks lurking beneath the rippling waters?","volume":"40","author":"Pelosi","year":"2019","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/eurheartj\/ehy437","article-title":"Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar","volume":"40","author":"Gutman","year":"2019","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/eurheartj\/ehab680","article-title":"Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence","volume":"43","author":"De Caterina","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/eurheartj\/ehab609","article-title":"Longitudinal strain in the management of cardiac AL amyloidosis: do we need it?","volume":"43","author":"Rapezzi","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/eurheartj\/ehab507","article-title":"Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis","volume":"43","author":"Cohen","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B8","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B9","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehaa458","article-title":"Transthyretin cardiac amyloidosis in patients with severe aortic stenosis","volume":"41","author":"Falk","year":"2020","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B10","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehaa131","article-title":"Untangling the physiology of transthyretin cardiac amyloidosis by leveraging echocardiographically derived pressure\u2013volume indices","volume":"41","author":"Rosenblum","year":"2020","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B12","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/eurheartj\/ehz298","article-title":"Treatment of cardiac transthyretin amyloidosis: an update","volume":"40","author":"Emdin","year":"2019","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/eurheartj\/ehz057","article-title":"Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis","volume":"40","author":"van den Berg","year":"2019","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/eurheartj\/ehz173","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"43","author":"Damy","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/eurheartj\/ehz205","article-title":"Transthyretin amyloidosis in Western Europe: a snapshot from the THAOS registry and a call for further perspectives","volume":"43","author":"Ammirati","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/eurheartj\/ehab629","article-title":"Primary care heart failure service identifies a missed cohort of heart failure patients with reduced ejection fraction","volume":"43","author":"Kahn","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/eurheartj\/ehab751","article-title":"Implementation science and potential for screening in heart failure","volume":"43","author":"Lund","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B18","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1093\/eurheartj\/ehab561","article-title":"SGLT2 inhibitors: the story continues to unfold","volume":"42","author":"Pi\u00f1a","year":"2021","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B19","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1093\/eurheartj\/ehaa344","article-title":"Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection fraction influenced by background therapy? Expectations and realities of a new standard of care","volume":"41","author":"Packer","year":"2020","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B20","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1093\/eurheartj\/ehaa530","article-title":"Regression of left ventricular hypertrophy with SGLT2 inhibitors","volume":"41","author":"Paneni","year":"2020","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B21","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab709","article-title":"Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights","volume":"43","author":"Sattar","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/eurheartj\/ehab798","article-title":"Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/eurheartj\/ehab828","article-title":"Re-emergence of heart failure with a normal ejection fraction?","volume":"43","author":"Kondo","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/eurheartj\/ehab837","article-title":"Respectful language and putting the person first with obesity","volume":"43","author":"Bajaj","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B25","article-title":"Obesity modifies the energetic phenotype of dilated cardiomyopathy","volume":"43","author":"Rayner","year":"2022","journal-title":"Eur Heart J"},{"key":"2022020922144217300_ehab906-B26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/eurheartj\/ehab840","article-title":"Investigating the disease is the key to the obesity stigma","volume":"43","author":"Rayner","year":"2022","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/5\/351\/42465162\/ehab906.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/5\/351\/42465162\/ehab906.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T09:06:36Z","timestamp":1674723996000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/5\/351\/6521629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,2,3]]},"published-print":{"date-parts":[[2022,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab906","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2022,2,1]]}}}